Buy SS-31 Online

SS-31 Peptide Research Overview, Uses & Key Information

SS-31, also known as Elamipretide, is a synthetic tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2) developed to target and protect mitochondria—the energy-producing organelles in cells.

It has shown potential in treating diseases related to mitochondrial dysfunction, including age-related degenerative conditions, cardiovascular diseases, and certain muscular and neurodegenerative disorders.

Mechanism of Action

Moreover, SS-31 is unique in its ability to penetrate cell membranes.

It accumulates in the inner mitochondrial membrane, where it binds cardiolipin, a phospholipid critical for maintaining mitochondrial structure and function.

Additionally, key actions include:

Additionally, stabilizing mitochondrial membranes supports cellular integrity.

Moreover, scavenging reactive oxygen species (ROS) lowers oxidative stress.

Consequently, improving ATP production supports cellular energy.

As a result, preventing apoptosis (programmed cell death).

Potential benefits

Additionally, SS-31 is being studied for a wide range of applications: moreover, you can buy SS-31 Online 

1. Mitochondrial Diseases

Helps restore normal mitochondrial function

Shown promise in conditions like Leber’s hereditary optic neuropathy (LHON) and Barth syndrome

2. Cardiovascular Health

May improve heart function in heart failure and ischemia-reperfusion injury

Enhances mitochondrial efficiency in cardiac cells

3. Muscle and Age-Related Degeneration

Shown to increase muscle endurance and strength in aged animals

Improves mitochondrial function in skeletal muscles

4. Neuroprotection

Potential therapeutic effects in Parkinson’s, Alzheimer’s, and other neurodegenerative diseases due to its antioxidant properties

Administration & Dosage

SS-31 is typically administered via subcutaneous or intravenous injection

Human dosing is still being optimized in clinical trials

Clinical Trials & Research

Elamipretide has undergone Phase 1 and 2 clinical trials for various conditions.

Some early trials show improvements in heart failure, mitochondrial myopathies, and age-related degeneration, though larger studies are ongoing to confirm efficacy and safety.

Safety and Side Effects

SS-31 has generally shown a good safety profile, with mild side effects including:

Injection site reactions

Headaches

Nausea (rare)

Long-term safety data is still being collected in human studies.

Conclusion

SS-31 (Elamipretide) represents a promising breakthrough in mitochondria-targeted therapy, with the potential to combat a wide range of age-related and degenerative diseases at the cellular energy level.

While still under clinical investigation, it is a strong candidate in the emerging field of mitochondrial medicine.